CLNINDIA · NSE: CLNINDIA · BSE: 506390
Q4 FY25 results · Jan–Mar 2025
CLNINDIA reported revenue from operations of ₹220.28 crore (up 7.5% from Q4 FY24) and net profit of ₹10.65 crore (up 82.3% from Q4 FY24) for Q4 FY25 (Jan–Mar 2025), on a standalone basis.
| Item | Q4 FY25 | Q4 FY24 | YoY | Q3 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 220.28 | 204.91 | +7.5% | 212.98 | +3.4% |
| Other income | 9.45 | 5.36 | +76.4% | 4.06 | +132.8% |
| Total income | 229.73 | 210.27 | +9.3% | 217.04 | +5.8% |
| Profit before tax | 12.75 | 8.66 | +47.2% | 23.24 | −45.1% |
| Net profit for the period | 10.65 | 5.84 | +82.3% | 17.22 | −38.2% |
| EPS, basic (₹) | 4.61 | 2.53 | +82.2% | 7.46 | −38.2% |
| Net margin (%) | 4.8 | 2.9 | 8.1 |
Standalone
- Filed with BSE
- 21 Jul 2025, 14:28 IST
- Board meeting
- 16 Jul 2025
- Period
- 01 Jan 2025 to 31 Mar 2025
- Review status
- Audited
- Source
- XBRL filing on BSE